Skip Navigation
Skip to contents

Diabetes Metab J : Diabetes & Metabolism Journal

Search
OPEN ACCESS

Search

Page Path
HOME > Search
1 "1,5-anhydroglucitol"
Filter
Filter
Article category
Keywords
Publication year
Authors
Funded articles
Original Article
1,5-Anhydroglucitol as a Useful Marker for Assessing Short-Term Glycemic Excursions in Type 1 Diabetes
Hannah Seok, Ji Hye Huh, Hyun Min Kim, Byung-Wan Lee, Eun Seok Kang, Hyun Chul Lee, Bong Soo Cha
Diabetes Metab J. 2015;39(2):164-170.   Published online March 9, 2015
DOI: https://doi.org/10.4093/dmj.2015.39.2.164
  • 4,085 View
  • 45 Download
  • 20 Web of Science
  • 19 Crossref
AbstractAbstract PDFPubReader   
Background

Type 1 diabetes is associated with more severe glycemic variability and more frequent hypoglycemia than type 2 diabetes. Glycemic variability is associated with poor glycemic control and diabetic complications. In this study, we demonstrate the clinical usefulness of serum 1,5-anhydroglucitol (1,5-AG) for assessing changes in glycemic excursion in type 1 diabetes.

Methods

Seventeen patients with type 1 diabetes were enrolled in this study. A continuous glucose monitoring system (CGMS) was applied twice at a 2-week interval to evaluate changes in glycemic variability. The changes in serum glycemic assays, including 1,5-AG, glycated albumin and hemoglobin A1c (HbA1c), were also evaluated.

Results

Most subjects showed severe glycemic excursions, including hypoglycemia and hyperglycemia. The change in 1,5-AG level was significantly correlated with changes in the glycemic excursion indices of the standard deviation (SD), mean amplitude of glucose excursion (MAGE), lability index, mean postmeal maximum glucose, and area under the curve for glucose above 180 mg/dL (r=-0.576, -0.613, -0.600, -0.630, and -0.500, respectively; all P<0.05). Changes in glycated albumin were correlated with changes in SD and MAGE (r=0.495 and 0.517, respectively; all P<0.05). However, changes in HbA1c were not correlated with any changes in the CGMS variables.

Conclusion

1,5-AG may be a useful marker for the assessment of short-term changes in glycemic variability. Furthermore, 1,5-AG may have clinical implications for the evaluation and treatment of glycemic excursions in type 1 diabetes.

Citations

Citations to this article as recorded by  
  • Glycemic dispersion: a new index for screening high glycemic variability
    Rui Shi, Lei Feng, Yan-Mei Liu, Wen-Bo Xu, Bei-Bei Luo, Ling-Tong Tang, Qian-Ye Bi, Hui-Ying Cao
    Diabetology & Metabolic Syndrome.2023;[Epub]     CrossRef
  • Digital Behavior Change Interventions to Reduce Sedentary Behavior and Promote Physical Activity in Adults with Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Xiaoyan Zhang, Xue Qiao, Ke Peng, Shan Gao, Yufang Hao
    International Journal of Behavioral Medicine.2023;[Epub]     CrossRef
  • DBS are suitable for 1,5-anhydroglucitol monitoring in GSD1b and G6PC3-deficient patients taking SGLT2 inhibitors to treat neutropenia
    Joseph P. Dewulf, Nathalie Chevalier, Sandrine Marie, Maria Veiga-da-Cunha
    Molecular Genetics and Metabolism.2023; 140(3): 107712.     CrossRef
  • The correlation between serum 1, 5-anhydroglucitol and β-cell function in Chinese adults with different glucose metabolism statuses
    Yuexing Yuan, Yuanyuan Tan, Yao Wang, Shanhu Qiu, Jiao Yang, Cheng Chen
    International Journal of Diabetes in Developing Countries.2023;[Epub]     CrossRef
  • HbA1c combined with glycated albumin or 1,5‐anhydroglucitol improves the efficiency of diabetes screening in a Chinese population
    Junyi Qian, Cheng Chen, Xiaohang Wang, Yuanyuan Tan, Jiao Yang, Yuexing Yuan, Juan Chen, Haijian Guo, Bei Wang, Zilin Sun, Yao Wang
    Diabetic Medicine.2022;[Epub]     CrossRef
  • Assessment of glycemia in chronic kidney disease
    Mohamed Hassanein, Tariq Shafi
    BMC Medicine.2022;[Epub]     CrossRef
  • Continuous subcutaneous insulin infusion alters microRNA expression and glycaemic variability in children with type 1 diabetes
    Emma S. Scott, Andrzej S. Januszewski, Luke M. Carroll, Gregory R. Fulcher, Mugdha V. Joglekar, Anandwardhan A. Hardikar, Timothy W. Jones, Elizabeth A. Davis, Alicia J. Jenkins
    Scientific Reports.2021;[Epub]     CrossRef
  • Red rice koji extract alleviates hyperglycemia by increasing glucose uptake and glucose transporter type 4 levels in skeletal muscle in two diabetic mouse models
    Takakazu Yagi, Koji Ataka, Kai-Chun Cheng, Hajime Suzuki, Keizaburo Ogata, Yumiko Yoshizaki, Kazunori Takamine, Ikuo Kato, Shouichi Miyawaki, Akio Inui, Akihiro Asakawa
    Food & Nutrition Research.2020;[Epub]     CrossRef
  • How tightly controlled do fluctuations in blood glucose levels need to be to reduce the risk of developing complications in people with Type 1 diabetes?
    R. Livingstone, J. G. Boyle, J. R. Petrie
    Diabetic Medicine.2020; 37(4): 513.     CrossRef
  • Resolution on the results of the first working meeting of the scientific advisory board «Actual problems of glycemic variability as a new criterion of glycemic control and safety of diabetes therapy»
    Mikhail B. Antsiferov, Gagik R. Galstyan, Alexey V. Zilov, Alexander Y. Mayorov, Tatyana N. Markova, Nikolay A. Demidov, Olga M. Koteshkova, Dmitry N. Laptev, Alisa V. Vitebskaya
    Diabetes mellitus.2019; 22(3): 281.     CrossRef
  • Hyperglycemia and Carotenoid Intake Are Associated with Serum Carotenoids in Youth with Type 1 Diabetes
    Namrata Sanjeevi, Leah M. Lipsky, Tonja R. Nansel
    Journal of the Academy of Nutrition and Dietetics.2019; 119(8): 1340.     CrossRef
  • Correlation of Serum 1,5-AG with Uric Acid in Type 2 Diabetes Mellitus with Different Renal Functions
    Kai Zhang, Bizhen Xue, Yuexing Yuan, Yao Wang
    International Journal of Endocrinology.2019; 2019: 1.     CrossRef
  • Glycaemic control and glycaemic variability in older people with diabetes
    Hermes J Florez
    The Lancet Diabetes & Endocrinology.2018; 6(6): 433.     CrossRef
  • Alternate glycemic markers reflect glycemic variability in continuous glucose monitoring in youth with prediabetes and type 2 diabetes
    Christine L. Chan, Laura Pyle, Megan M. Kelsey, Lindsey Newnes, Amy Baumgartner, Philip S. Zeitler, Kristen J. Nadeau
    Pediatric Diabetes.2017; 18(7): 629.     CrossRef
  • 1,5-anidroglucitolo: un marcatore non tradizionale di iperglicemia
    Gabriella Lavalle, Roberto Testa, Maria Elisabetta Onori, Raffaella Vero, Anna Vero
    La Rivista Italiana della Medicina di Laboratorio - Italian Journal of Laboratory Medicine.2017; 13(3-4): 139.     CrossRef
  • Glycemic control and variability in association with body mass index and body composition over 18months in youth with type 1 diabetes
    Leah M. Lipsky, Benjamin Gee, Aiyi Liu, Tonja R. Nansel
    Diabetes Research and Clinical Practice.2016; 120: 97.     CrossRef
  • How Can We Easily Measure Glycemic Variability in Diabetes Mellitus?
    Suk Chon
    Diabetes & Metabolism Journal.2015; 39(2): 114.     CrossRef
  • Alternative biomarkers for assessing glycemic control in diabetes: fructosamine, glycated albumin, and 1,5-anhydroglucitol
    Ji-Eun Lee
    Annals of Pediatric Endocrinology & Metabolism.2015; 20(2): 74.     CrossRef
  • Glycemic Variability: How Do We Measure It and Why Is It Important?
    Sunghwan Suh, Jae Hyeon Kim
    Diabetes & Metabolism Journal.2015; 39(4): 273.     CrossRef

Diabetes Metab J : Diabetes & Metabolism Journal